Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kimberly Levinson

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Gynecologic Oncology Reports|September 21, 2020
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgerySally Mullany, David Scott Miller, Katina Robison, et al.
American Journal of Obstetrics and Gynecology|May 21, 2020
Basic social resource needs screening in the gynecologic oncology clinic: a quality improvement initiativeAnna Louise Beavis, Awa Sanneh, Rebecca L Stone, et al.
Cell & Bioscience|December 25, 2024
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methodsShiwen Peng, Darrell Fan, Hsin-Fang Tu, et al.
Gynecologic Oncology|February 23, 2020
The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth ratesStefany Acosta-Torres, Tricia Murdock, Rayna Matsuno, et al.
Gynecologic Oncology|February 2, 2020
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)Cornelia L Trimble, Kimberly Levinson, Leonel Maldonado, et al.
Gynecologic Oncology|June 12, 2026
Raising the bar on surgical site infection bundles: Preoperative penicillin allergy testing in gynecologic oncology patients with a reported penicillin allergy - A quality improvement studyNerlyne Desravines, Megan M Tschudy, Dana Hazimeh, et al.
The American Journal of Surgical Pathology|April 9, 2025
Clinicopathologic and Molecular Analysis of Malignant Neoplasms With Yolk Sac Tumor Differentiation in Women 40 Years of Age and OlderTricia A Numan, Brigitte M Ronnett, Lisa Haley, et al.
Gynecologic Oncology|September 11, 2013
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?Stephanie Ricci, Robert L Giuntoli, Eric Eisenhauer, et al.
JCO Global Oncology|February 13, 2025
Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider's PerspectivesBabayemi O Olakunde, Ngozi Idemili-Aronu, Tara M Friebel-Klingner, et al.
JCO Global Oncology|October 8, 2025
Barriers and Facilitators to Cancer Clinical Trial Participation: Perspectives of Patients in the ICON-3 Practice-Based Research Network, NigeriaNgozi Idemili-Aronu, Babayemi O Olakunde, Tara M Friebel-Klingner, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Gynecologic Oncology Reports|September 21, 2020
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgerySally Mullany, David Scott Miller, Katina Robison, et al.
American Journal of Obstetrics and Gynecology|May 21, 2020
Basic social resource needs screening in the gynecologic oncology clinic: a quality improvement initiativeAnna Louise Beavis, Awa Sanneh, Rebecca L Stone, et al.
Cell & Bioscience|December 25, 2024
Improved efficacy of therapeutic HPV DNA vaccine using intramuscular injection with electroporation compared to conventional needle and needle-free jet injector methodsShiwen Peng, Darrell Fan, Hsin-Fang Tu, et al.
Gynecologic Oncology|February 23, 2020
The addition of metformin to progestin therapy in the fertility-sparing treatment of women with atypical hyperplasia/endometrial intraepithelial neoplasia or endometrial cancer: Little impact on response and low live-birth ratesStefany Acosta-Torres, Tricia Murdock, Rayna Matsuno, et al.
Gynecologic Oncology|February 2, 2020
A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3)Cornelia L Trimble, Kimberly Levinson, Leonel Maldonado, et al.
Gynecologic Oncology|June 12, 2026
Raising the bar on surgical site infection bundles: Preoperative penicillin allergy testing in gynecologic oncology patients with a reported penicillin allergy - A quality improvement studyNerlyne Desravines, Megan M Tschudy, Dana Hazimeh, et al.
The American Journal of Surgical Pathology|April 9, 2025
Clinicopathologic and Molecular Analysis of Malignant Neoplasms With Yolk Sac Tumor Differentiation in Women 40 Years of Age and OlderTricia A Numan, Brigitte M Ronnett, Lisa Haley, et al.
Gynecologic Oncology|September 11, 2013
Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?Stephanie Ricci, Robert L Giuntoli, Eric Eisenhauer, et al.
JCO Global Oncology|February 13, 2025
Optimizing Recruitment and Retention in Cancer Clinical Trials in Low-Resource Settings: Barriers and Facilitators From Nigerian Provider's PerspectivesBabayemi O Olakunde, Ngozi Idemili-Aronu, Tara M Friebel-Klingner, et al.
JCO Global Oncology|October 8, 2025
Barriers and Facilitators to Cancer Clinical Trial Participation: Perspectives of Patients in the ICON-3 Practice-Based Research Network, NigeriaNgozi Idemili-Aronu, Babayemi O Olakunde, Tara M Friebel-Klingner, et al.
Pageof 4